Current Research Studies
A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Ruxolitinib cream for Vitiligo
What is the goal of the study?
Randomized, double-blind, vehicle-controlled study with an openlabel, treatment-extension period. Studying the Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Who can participate in the study?
Please contact the study team listed below to learn more.